Research Topics
| Ashesh B JaniSummaryAffiliation: University of Chicago Country: USA Publications
| Collaborators
|
Detail Information
Publications
Volume rendering quantification algorithm for reconstruction of CT volume-rendered structures: Part I. Cerebral arteriovenous malformationsA B Jani
Department of Radiation Oncology, University of Chicago Hospitals, IL 60637, USA
IEEE Trans Med Imaging 19:12-24. 2000..Applications and potential expansions of VRQA are discussed...
Late radiotherapy toxicity after prostate cancer treatment: influence of hormonal therapyAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, Illinois 60637, USA
Urology 66:566-70. 2005..To analyze the impact of hormonal therapy (HT) on late gastrointestinal (GI) and genitourinary (GU) toxicity from external beam radiotherapy (RT)...
Analysis of prostate-specific antigen rebound interval in patients with prostate cancer receiving hormonal therapy and external-beam radiation therapyAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, IL 60637, USA
Clin Prostate Cancer 3:43-8. 2004..Excluding RI failures can marginally improve specificity but may possibly have an unacceptable risk of lowering sensitivity. Further work is needed to design and validate definitions of failure, which account for the RI...
The effectiveness of combining hormone therapy and radiotherapy in the treatment of prostate cancerAshesh B Jani
University of Chicago Hospitals, Department of Radiation and Cellular Oncology, 5758 S Maryland Ave, MC 9006, Chicago, IL 60637, USA
Expert Opin Pharmacother 5:2469-77. 2004..Further data are needed in order to identify the optimum target population, combination of agents, and hormone duration, as a function of patient and disease factors...
Influence of intensity-modulated radiotherapy on acute genitourinary and gastrointestinal toxicity in the treatment of localized prostate cancerAshesh B Jani
Dept of Radiation and Cellular Oncology, University of Chicago Hospitals, 5758 S Maryland Ave, MC 9006, Chicago, IL 60637, USA
Technol Cancer Res Treat 6:11-5. 2007....
Approaching clinical problems in prostate cancer radiotherapy using the number needed to treat (NNT) techniqueAshesh B Jani
The Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, USA
Cancer Invest 24:318-27. 2006..Limitations of NNT calculations based on non-randomized comparisons also are discussed...
Impact on late toxicity of using transabdominal ultrasound for prostate cancer patients treated with intensity modulated radiotherapyAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, 5758 S Maryland Ave, MC 9006, Chicago, IL 60637 USA
Technol Cancer Res Treat 4:115-20. 2005..Further efforts, perhaps better undertaken in a multi-institutional setting, are needed to determine whether BAT use can significantly reduce late GI toxicity...
Role of external beam radiotherapy with low-dose-rate brachytherapy in treatment of prostate cancerAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, Illinois 60637, USA
Urology 67:1007-11. 2006..EBRT is often used in addition to low-dose-rate brachytherapy in the treatment of prostate cancer, particularly for disease with adverse features...
Postprostatectomy adjuvant versus salvage radiotherapy: a complication-adjusted number-needed-to-treat analysisAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, Illinois 60637, USA
Cancer 103:1833-42. 2005..The purpose of the current investigation was to systematically compare adjuvant versus salvage RT in a manner that incorporates both treatment efficacy and complications...
Analysis of acute toxicity with use of transabdominal ultrasonography for prostate positioning during intensity-modulated radiotherapyAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, Illinois 60637, USA
Urology 65:504-8. 2005....
Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancerAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, Illinois 60637, USA
Urology 65:1157-62. 2005..Improved understanding of the influence of age on toxicity outcome after RT for prostate cancer can assist in treatment decision-making...
Opacity transfer function optimization for volume-rendered computed tomography images of the prostateAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, 5758 S Maryland Avenue, MC 9006, Chicago, IL 60637, USA
Acad Radiol 12:761-70. 2005..The selection of an opacity transfer function is essential for volume visualization. Computed tomography (CT) scans of the pelvis were used to determine an optimal opacity transfer function for use in radiotherapy...
Impact of hormone therapy on acute radiotherapy toxicity in the treatment of prostate cancerA B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, IL 60637, USA
Prostate Cancer Prostatic Dis 8:224-8. 2005..To analyze the impact of neoadjuvant hormone therapy (HT) on acute gastrointestinal (GI) and genitourinary (GU) toxicity from radiotherapy (RT)...
Analysis of impact of age and race on biochemical control after radiotherapy in different prostate cancer settingsAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, Illinois 60637, USA
Urology 66:124-9. 2005..Proper understanding of these prognostic factors can assist in both treatment decision-making and the general understanding of the natural history of prostate cancer...
Intensity-modulated radiation therapy for prostate cancerAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
Clin Prostate Cancer 2:98-105. 2003..In addition, future directions of prostate IMRT, both technologic and clinical, are discussed...
Analysis of the role of adjuvant chemotherapy for invasive carcinoma of the esophagusA B Jani
Department of Radiation and Cellular Oncology, University of Chicago, Illinois, USA
Am J Clin Oncol 23:554-8. 2000....
Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicityAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, Illinois 60637, USA
Urology 67:147-51. 2006..To provide a single-institution analysis of the influence of pelvic intensity-modulated radiotherapy (RT) on acute genitourinary (GU) and gastrointestinal (GI) toxicity...
Radioimmunoscintigraphy for postprostatectomy radiotherapy: analysis of toxicity and biochemical controlAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago, Illinois, USA
J Nucl Med 45:1315-22. 2004..Our goal was to evaluate the role of radioimmunoscintigraphy (RIS) directed against prostate-specific membrane antigen (PSMA) in influencing postprostatectomy radiotherapy (RT) toxicity and biochemical control...
Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapyLoren K Mell
Department of Radiation and Cellular Oncology, University of Chicago and University of Illinois at Chicago, Chicago, IL 60637, USA
Int J Radiat Oncol Biol Phys 70:1431-7. 2008....
A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by ageBreanne E Terakedis
Department of Radiation Oncology, Emory University, Atlanta, GA, USA
Am J Clin Oncol 33:619-23. 2010....
A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapyKiran Devisetty
Department of Radiation and Cellular Oncology, University of Chicago, IL, USA
Radiother Oncol 93:298-301. 2009..For V(30)>450 cc and < or =450 cc, acute GI toxicity was 33% and 8%, respectively (p=0.003)...
Influence of radioimmunoscintigraphy on postprostatectomy radiotherapy treatment decision makingAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, USA
J Nucl Med 45:571-8. 2004..The aim of this study was to evaluate the role of radioimmunoscintigraphy (RIS) directed against prostate-specific membrane antigen (PSMA) in influencing postradical retropubic prostatectomy (RRP) radiotherapy (RT) decision making...
Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcomeMichael T Milano
Department of Radiation and Cellular Oncology, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL 60637, USA
Int J Radiat Oncol Biol Phys 63:354-61. 2005..Compared with historical controls, local control is not compromised despite efforts to increase conformality and reduce normal structure dose...
Impact of hormone therapy when combined with external beam radiotherapy for early-stage, intermediate-, or high-risk prostate cancerAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago, IL, USA
Am J Clin Oncol 26:382-5. 2003..27.0%). Thus, biochemical failure decreased with the administration of hormone therapy in this group of patients with early stage, intermediate- or high-risk prostate cancer. This finding requires validation by ongoing randomized trials...
External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicityKiran Devisetty
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
Int J Radiat Oncol Biol Phys 77:1060-5. 2010..To describe genitourinary (GU) toxicity in men with a history of transurethral resection of the prostate (TURP) treated with external beam radiation therapy (EBRT) for prostate cancer...
Late rectal toxicity after prostate brachytherapy: influence of supplemental external beam radiation on dose-volume histogram analysisKapila Kalakota
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, IL 60637, USA
Brachytherapy 9:131-6. 2010..To describe the rate of gastrointestinal (GI) toxicity after prostate brachytherapy and describe how external beam radiation therapy (EBRT) may influence the association of rectal dose-volume histogram (DVH) parameters with rectal toxicity...
Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapyStanley L Liauw
Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA
Int J Radiat Oncol Biol Phys 77:125-30. 2010..The present study reviewed the outcomes of intermediate- and high-risk men treated with RT and short-term ADT...
Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcomeMichael T Milano
Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA
Int J Radiat Oncol Biol Phys 59:445-53. 2004..To assess the efficacy and toxicity of intensity-modulated radiotherapy (IMRT) in pancreatic and bile duct (cholangiocarcinoma) malignancies...
The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapyKevin S Choe
Department Radiation and Cellular Oncology, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA
Cancer 116:1820-6. 2010..The potential antineoplastic effect of ACs was investigated in patients who received radiotherapy for localized prostate cancer...
Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancerPeter J Rossi
Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA
Radiother Oncol 90:353-8. 2009..The purpose of this report is to evaluate the movement of the planning target volume (PTV) in relation to the pelvic lymph nodes (PLNs) during treatment of high-risk prostate cancer...
Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experienceJoseph K Salama
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
J Clin Oncol 25:4581-6. 2007..To report a multicenter experience treating anal canal cancer patients with concurrent chemotherapy and intensity-modulated radiation therapy (IMRT)...
Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysisAshesh B Jani
Department of Radiation Oncology, Emory University, Atlanta, Georgia 30322, USA
Am J Clin Oncol 33:168-72. 2010..Our objectives were to analyze time trends in the use of surgery and RT and type of RT (external beam RT [EBRT], brachytherapy [Brachy] or combination EBRT + Brachy [Combo])...
Impact of radioimmunoscintigraphy on definition of clinical target volume for radiotherapy after prostatectomyAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, 5758 S Maryland Avenue, MC 9006, Chicago, IL 60637, USA
J Nucl Med 45:238-46. 2004..The goal of this study was to evaluate the role of radioimmunoscintigraphy (RIS) directed against prostate-specific membrane antigen in modifying postprostatectomy prostate fossa clinical target volume (CTV) definition...
Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive coresStanley L Liauw
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, USA
Cancer 115:1784-90. 2009..However, the value of concurrent ADT was less certain with dose-escalated RT. Better methods of stratifying patients in this risk group may help select patients who are most likely to benefit...
Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysisAshesh B Jani
Department of Radiation Oncology, Emory University, Atlanta, GA 30322, USA
Am J Clin Oncol 31:375-8. 2008..The objective of this investigation was to use the Surveillance, Epidemiology, and End Results (SEER) registry to examine time trends in age and grade...
Postprostatectomy target-normal structure overlap volume differences using computed tomography and radioimmunoscintigraphy images for radiotherapy treatment planningAndy Su
Department of Radiation and Cellular Oncology, University of Illinois at Chicago, Chicago, IL 60637, USA
Clin Nucl Med 31:139-44. 2006....
Management strategies for locally advanced prostate cancerAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, Illinois 60637, USA
Drugs Aging 23:119-29. 2006..Finally, novel investigational strategies such as chemotherapy and gene therapy are being applied in an attempt to improve outcomes of locally advanced prostate cancer patients...
Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?Stanley L Liauw
Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, 5758 S Maryland Avenue, Chicago, IL 60637, USA
Int J Radiat Oncol Biol Phys 71:1316-21. 2008..Radioimmunoscintigraphy (RIS) has the potential to demonstrate early recurrences after prostatectomy and might be useful in selecting patients for salvage radiotherapy (RT)...
Pelvic shape and prostate motion: implications for target volume design and analysis of acute toxicityAshesh B Jani
Department of Radiation Oncology, Emory University, Atlanta, GA 30322, USA
Am J Clin Oncol 32:291-5. 2009..To study the impact of pelvic shape on prostate motion and the implications for radiotherapy target design and treatment outcomes...
External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?Kevin S Choe
Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA
Int J Radiat Oncol Biol Phys 76:755-60. 2010..To characterize the bleeding toxicity associated with external beam radiotherapy for prostate cancer patients receiving anticoagulation (AC) therapy...
Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma: a complication-adjusted number-needed-to-treat analysisAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois 60637, USA
Cancer 98:2351-61. 2003....
Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysisAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, USA
BMC Cancer 3:16. 2003....
Hormone therapy and radiotherapy for early prostate cancer: a utility-adjusted number needed to treat (NNT) analysisAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago, 5758 S. Maryland Avenue, MC 9001, Chicago, IL 60637, USA
Int J Radiat Oncol Biol Phys 61:687-94. 2005....
External beam radiotherapy for prostate cancer: urinary outcomes for men with high International Prostate Symptom Scores (IPSS)Renuka Malik
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
Int J Radiat Oncol Biol Phys 80:1080-6. 2011..To report the urinary outcome of men treated for prostate cancer with external beam radiotherapy (EBRT) who have pretreatment obstructive urinary symptoms (International Prostate Symptom Score [IPSS] ≥ 15)...
Lymphadenectomy for patients with cervical cancer: is it of value?Peter J Rossi
Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA
J Surg Oncol 100:404-6. 2009..The purpose of this Surveillance Epidemiology and End Results (SEER) analysis was to assess the value of lymphadenectomy (LND) in patients with cervical cancer...
Androgen ablation adjuvant to postprostatectomy radiotherapy: complication-adjusted number needed to treat analysisAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, Illinois 60637, USA
Urology 64:976-81. 2004....
Early prostate cancer: hedonic prices model of provider-patient interactions and decisionsAshesh B Jani
Department of Radiation Oncology, Emory University, Atlanta, GA 30322, USA
Int J Radiat Oncol Biol Phys 70:1158-68. 2008..To determine the relative influence of treatment features and treatment availabilities on final treatment decisions in early prostate cancer...
Toxicity analysis of dose escalation from 75.6 gy to 81.0 gy in prostate cancerNatalie Xu
Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA
Am J Clin Oncol 34:11-5. 2011..Our objective was to perform a toxicity analysis of a minor dose escalation (from 75.6 to 81.0 Gy) within this "high-dose" range...
A case study of radiotherapy planning for a bilateral metal hip prosthesis prostate cancer patientAndy Su
Department of Radiation and Cellular Oncology, The University of Chicago Hospitals, Chicago, IL 60637, USA
Med Dosim 30:169-75. 2005..The work described herein may also have applicability to other groups of patients, such as those with gynecological or other pelvic malignancies...
Performance evaluation of Calypso 4D localization and kilovoltage image guidance systems for interfraction motion management of prostate patientsTomi Ogunleye
Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA
ScientificWorldJournal 9:449-58. 2009..Implications for Calypso's role as a QA tool are discussed...
Applying population dynamics modeling to patients with lymph node positive prostate cancerPeter A S Johnstone
Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia 30322, USA
J Urol 178:1952-5; discussion 1955-6. 2007..Patients with prostate cancer and positive lymph nodes are often considered to be doomed to distant failure. We applied these models to that population to examine whether those data support this presumption...
Quantitative evaluation of a cone-beam computed tomography-planning computed tomography deformable image registration method for adaptive radiation therapyJoshua D Lawson
Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA
J Appl Clin Med Phys 8:2432. 2007..The method is completely automated, applicable to any chosen registration algorithm, and does not require user interaction of any kind...
Prostate-specific antigen halving time while on neoadjuvant androgen deprivation therapy is associated with biochemical control in men treated with radiation therapy for localized prostate cancerRenuka Malik
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
Int J Radiat Oncol Biol Phys 79:1022-8. 2011..To assess whether the PSA response to neoadjuvant androgen deprivation therapy (ADT) is associated with biochemical control in men treated with radiation therapy (RT) for prostate cancer...
The role of indium-111 radioimmunoscintigraphy in post-radical retropubic prostatectomy management of prostate cancer patientsAshesh B Jani
Department of Radiation Oncology, Emory University, 1365 Clifton Road, NE, Suite A1300, Atlanta, GA 30322, USA
Clin Med Res 5:123-31. 2007..The larger RIS-guided target volumes do not appear to be prohibitive in increasing radiotherapy-related toxicity. Future directions of the use of RIS for post-RRP prostate cancer are discussed...
Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysisPeter J Rossi
Department of Radiation Oncology, Emory University School of Medicine, 1365 Clifton Rd, NE, Atlanta, GA 30322, USA
Int J Radiat Oncol Biol Phys 70:134-8. 2008..To assess the role of radiotherapy (RT) in women with Stage IIIC endometrial cancer...
Role of androgen ablation with low-dose-rate brachytherapy in the treatment of prostate cancerAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, USA
Clin Drug Investig 26:723-31. 2006..We report a single-institution experience and analysis of the role of androgen ablation with brachytherapy in patients with prostate cancer...
Selecting a secondary treatmentNancy B Davis
Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medical Center, 5841 South Maryland Avenue, MC2115, Chicago, IL 60637, USA
Urol Clin North Am 30:403-14. 2003..ketoconazole. and chemotherapy. At each interval, clinical trials should be offered since none of these maneuvers are proven to prolong life...
Intensity-modulated radiotherapy for neoadjuvant treatment of gastric cancerBrian Knab
Department of Radiation and Cellular Oncology, The University of Chicago Hospitals, Chicago, IL, USA
Med Dosim 31:292-7. 2006..In conclusion, our study suggests a dosimetric benefit of IMRT over conventional planning, and suggests an important role for IMRT in the neoadjuvant treatment of gastric cancer...
Early prostate cancer: clinical decision-makingAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
Lancet 361:1045-53. 2003..Here, we review the major treatment options, discuss their relative advantages and disadvantages, and provide a general approach to management of patients with early-stage prostate cancer...
Case study of anti-1-amino-3-F-18 fluorocyclobutane-1-carboxylic acid (anti-[F-18] FACBC) to guide prostate cancer radiotherapy target designAshesh B Jani
Department of Radiation Oncology, Emory University, Atlanta, Georgia 30322, USA
Clin Nucl Med 34:279-84. 2009..Here we describe a case of a prostate cancer patient who underwent radiation treatment and had an FACBC scan obtained as part of a pilot study...
The application of number needed to treat (NNT) to clinical problems in radiotherapyAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago, 5758 S Maryland Ave, MC 9006, Chicago, IL 60637, USA
Cancer Invest 22:262-70. 2004....
Influence of demographic factors on outcome of collecting duct carcinoma: a Surveillance, Epidemiology, and End Results (SEER) database analysisJoseph M Pepek
Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA
Clin Genitourin Cancer 7:E24-7. 2009..Collecting duct carcinoma (CDC) is a rare tumor that is difficult to analyze in a single-institution setting. The Surveillance, Epidemiology, and End Results (SEER) database was used to examine demographics and outcomes of CDC...
Chronic genitourinary and gastrointestinal toxicity of prostate cancer patients undergoing pelvic radiotherapy with intensity-modulated versus 4-field techniqueAndy W Su
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, IL 60637, USA
Am J Clin Oncol 30:215-9. 2007..To compare chronic GU and GI toxicity of pelvic radiotherapy delivered using intensity-modulated radiotherapy (IMRT) versus conventional 4-field technique...
An electronic application for rapidly calculating Charlson comorbidity scoreWilliam H Hall
University of California, Davis, Department of Radiation Oncology, UC Davis Cancer Center, 4501 X Street, G126, Sacramento, CA 95817, USA
BMC Cancer 4:94. 2004..Unfortunately, the use of such scales has yet to be widely integrated into either clinical practice or clinical trials research...
A review of low-dose-rate prostate brachytherapy--techniques and outcomesDavid M Marcus
Department of Radiation Oncology, Emory University School of Medicine, GA 30322, USA
J Natl Med Assoc 102:500-10. 2010..As research in prostate brachytherapy continues, it is likely that this modality will play an increasingly important role in the treatment of early-stage prostate cancer patients in the future...
Dosimetric quality endpoints for low-dose-rate prostate brachytherapy using biological effective dose (BED) vs. conventional doseRachana Singh
Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, IL 60637, USA
Med Dosim 28:255-9. 2003..This methodology can be applied to analyze BED dosimetric endpoints to improve clinical outcome and reduce complications of prostate brachytherapy...
Is there an association between multiple myeloma and prostate cancer?Johnny Kao
Department of Radiation and Cellular Oncology, University of Chicago, 5758 South Maryland Avenue, MC 9006, Chicago, IL 60637, USA
Med Hypotheses 63:226-31. 2004....
Organ motion and IMRT in prostate cancer therapyAshesh B Jani
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois 60637, USA
Cancer J 9:244-6. 2003
Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibodyM E Lacouture
Section of Dermatology, Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
Clin Exp Dermatol 30:46-8. 2005..These are two of the few cases in the literature showing that rituximab is an effective and well-tolerated treatment for radiotherapy-relapsing primary cutaneous B cell lymphoma...
Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancerS L Liauw
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
Technol Cancer Res Treat 8:201-6. 2009..By last follow-up late Grade 3+ toxicity was 2% for both GI and GU systems. In conclusion, patients treated with IMRT for prostate cancer have excellent rates of biochemical control and low rates of severe toxicity of treatment...
Oral vitamin a therapy for a patient with a severely symptomatic postradiation anal ulceration: report of a caseJosh Levitsky
Section of Gastroenterology, Department of Medicine, University of Chicago Hospitals, Chicago, Illinois, USA
Dis Colon Rectum 46:679-82. 2003..Vitamin A seems to be very effective in the treatment of radiation-induced anorectal damage, with little toxicity and expense...
Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fieldsA B Jani
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
Prostate Cancer Prostatic Dis 10:82-6. 2007..006) predicted reduction in late GI toxicity but no factors correlated with late GU toxicity. IMRT did not influence late GU toxicity but was associated with a reduction of late GI toxicity over ConvRT...
Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniquesM T Milano
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
Br J Radiol 79:497-503. 2006..1% and median 5.8%). IMRT in the treatment of gastric malignancies reduces the mean and above threshold doses to critical normal tissues. In an initial cohort of seven patients, 50.4 Gy delivered by IMRT is well tolerated and safe...
Sentinel lymph node versus axillary lymph node dissection for early-stage breast carcinoma: a comparison using a utility-adjusted number needed to treat analysisAshesh B Jani
Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois 60637, USA
Cancer 97:359-66. 2003..This finding is quite robust and was found to remain constant over a range of values for utility and lymph node prevalence...
Accuracy and reliability of the endoscopic classification of chronic radiation-induced proctopathy using a novel grading methodKenneth D Chi
Department of Medicine, Section of Gastroenterology, University of Chicago, Chicago, IL 60637, USA
J Clin Gastroenterol 39:42-6. 2005..1%); 73% of patients referred for bleeding control were RTD grade 2 or 3. CONCLUSIONS: The RTD grading scale for radiation proctopathy is reproducible among endoscopists. Hematochezia is associated with high RTD grade...
The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancerW H Hall
Department of Radiation Oncology, UC Davis Cancer Center, University of California, Davis, 4501 X Street, Sacramento, CA 95817, USA
Prostate Cancer Prostatic Dis 8:22-30. 2005..Several clinical vignettes are provided to demonstrate the potential clinical utility of the CCI as applied to prostate cancer...
Sparing of the penile bulb and proximal penile structures with intensity-modulated radiation therapy for prostate cancerJ Kao
University of Chicago/University of Illinois at Chicago Department of Radiation Oncology, 5758 S. Maryland Avenue, MC 9006, Chicago, IL 60637, USA
Br J Radiol 77:129-36. 2004..4% vs 21.9%, p=0.003) but the volumes of bladder receiving 70 Gy were similar (p=0.3). IMRT may potentially reduce long term sexual morbidity by reducing the dose to the majority of the penile bulb...
Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experienceP P Connell
Department of Radiation and Cellular Oncology, University of Chicago, Micheal Reese Center for Radiation Therapy, Chicago, IL, USA
J Clin Oncol 19:54-61. 2001..36). CONCLUSION: Conformal RT is equally effective for AA and W patients. More research is needed in order to understand and correct the advanced presentations in AA men. These data suggest a need for early screening in AA populations...
Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA eraA B Jani
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, USA
Int J Cancer 96:363-71. 2001..For whites, the trends are more complex and more dependent on region. These findings should be used for future clinical and health-policy decisions in the screening and treatment of prostate cancer...
Biological effective dose for comparison and combination of external beam and low-dose rate interstitial brachytherapy prostate cancer treatment plansAshesh B Jani
Department of Radiation and Cellular Oncology and Urology, University of Chicago Hospitals Chicago, IL USA
Med Dosim 29:42-8. 2004..The results of this analysis can assist physicians in quantitatively determining the best combination and weighting of radiation treatment modalities for individual patients...
A critical review of variables affecting the accuracy and false-negative rate of sentinel node biopsy procedures in early breast cancerVani Vijayakumar
Nuclear Medicine Section, Department of Radiology, University of Texas Medical Branch, Galveston, Texas 77555 0793, USA
Nucl Med Commun 26:395-405. 2005..In this review, the factors that influence the success of different techniques are examined, and studies which have investigated false-negative rates and/or sentinel lymph node identification rates are summarized...
Prostate cancer and raceOtis W Brawley
Department of Hematology and Oncology, Emory School of Medicine, Emory University, Atlanta, Georgia, USA
Curr Probl Cancer 31:211-25. 2007
Integration of databases for radiotherapy outcomes analysesAshesh B Jani
Department of Radiation Oncology, Emory University, Atlanta, Georgia 30322, USA
J Am Coll Radiol 4:825-31. 2007..This bioinformatics database was successfully queried in a manner that allowed streamlining data flow of relevance to radiotherapy outcomes studies. Future directions of the application of this integration are discussed...
Recent developments in nuclear medicine in the management of bone metastases: a review and perspectiveVenugopal Damerla
New Hanover Regional Medical Center, University of North Carolina at Chapel Hill, Wilmington, North Carolina, USA
Am J Clin Oncol 28:513-20. 2005..Data from clinical collaborations will help optimize radiopharmaceutical therapy for pain palliation, increase its awareness among oncologists, and contribute effectively to patient palliation and quality-of-life improvements...
